Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Customer A | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage			13.90%
Customer A | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage		19.10%
Customer B | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage	11.30%	12.20%
Genentech, Inc. and Roche Group | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	41.90%	55.80%	42.10%